CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Cash flows from operating activities:
Net (loss) income	$ (181,600,000)	$ 160,600,000
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Depreciation	103,800,000	101,600,000
Amortization of intangible assets	142,600,000	142,900,000
Amortization of deferred financing costs	3,400,000	2,100,000
Fixed asset impairment	2,400,000	33,400,000
Goodwill impairment	156,600,000	0
Indefinite-lived intangible asset impairment	38,700,000	5,300,000
Definite-lived intangible asset impairment	0	3,800,000
Deferred income taxes	(52,700,000)	(39,900,000)
Stock based compensation expense	36,200,000	49,800,000
Restructuring and other costs - non-cash	5,800,000	15,200,000
Other non-cash income	(4,700,000)	(12,400,000)
Loss on disposal of property, plant and equipment	700,000	2,900,000
Gain on divestiture of noncontrolling interest	0	(8,700,000)
Loss on sale of non-strategic businesses and product lines	0	14,000,000.0
Changes in operating assets and liabilities, net of acquisitions:
Accounts and notes receivable-trade, net	149,100,000	(20,700,000)
Inventories, net	73,800,000	(48,400,000)
Prepaid expenses and other current assets	50,200,000	(3,600,000)
Other noncurrent assets	8,000,000.0	(14,400,000)
Accounts payable	(64,700,000)	(30,500,000)
Accrued liabilities	(72,600,000)	(35,500,000)
Income taxes	(9,900,000)	11,400,000
Other noncurrent liabilities	(13,600,000)	4,600,000
Net cash provided by operating activities	371,500,000	333,500,000
Cash flows from investing activities:
Capital expenditures	(60,000,000.0)	(86,900,000)
Cash paid for acquisitions of businesses and equity investments, net of cash acquired	(2,000,000.0)	(3,300,000)
Cash received on sale of non-strategic businesses or product lines	0	11,600,000
Cash received on derivative contracts	57,800,000	34,500,000
Cash paid on derivative contracts	(900,000)	0
Liquidation of short term investments	0	100,000
Proceeds from sale of property, plant and equipment, net	700,000	4,300,000
Net cash used in investing activities	(4,400,000)	(39,700,000)
Cash flows from financing activities:
Repayments on short-term borrowings	(1,200,000)	(67,400,000)
Cash paid for treasury stock	(140,000,000.0)	(160,000,000.0)
Cash dividends paid	(65,900,000)	(58,700,000)
Cash paid for acquisition of noncontrolling interest of consolidated subsidiary	(2,300,000)	0
Proceeds from long-term borrowings	1,448,500,000	119,600,000
Repayments of long-term borrowings	(701,000,000.0)	(251,200,000)
Deferred financing costs	(6,300,000)	(700,000)
Proceeds from exercised stock options	6,000,000.0	78,800,000
Cash paid for contingent consideration on prior acquisitions	(3,000,000.0)	(30,700,000)
Cash paid on derivative contracts	(30,500,000)	0
Net cash provided by (used in) financing activities	504,300,000	(370,300,000)
Effect of exchange rate changes on cash and cash equivalents	(4,300,000)	(7,000,000.0)
Net increase (decrease) in cash and cash equivalents	867,100,000	(83,500,000)
Cash and cash equivalents at beginning of period	404,900,000	309,600,000
Cash and cash equivalents at end of period	$ 1,272,000,000.0	$ 226,100,000